NuGen Medical Devices Inc. (TSXV: NGMD)
Canada
· Delayed Price · Currency is CAD 0.0800
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST
NuGen Medical Devices Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 9.34 | 0.46 | 0.13 | 1.75 | 0.27 | 0 | Upgrade
|
| Cash & Short-Term Investments | 9.34 | 0.46 | 0.13 | 1.75 | 0.27 | 0 | Upgrade
|
| Cash Growth | 461.15% | 253.33% | -92.49% | 556.92% | 13622.26% | -99.90% | Upgrade
|
| Accounts Receivable | 0.02 | 0.02 | 0.01 | 0.01 | 0 | - | Upgrade
|
| Other Receivables | 0.19 | 0.33 | 0.24 | 0.3 | 0.14 | 0.3 | Upgrade
|
| Receivables | 0.21 | 0.36 | 0.24 | 0.31 | 0.15 | 0.3 | Upgrade
|
| Inventory | 0.34 | 0.21 | 0.08 | 0.01 | 0.01 | - | Upgrade
|
| Prepaid Expenses | 0.12 | 0.25 | 0.12 | 0.07 | 0.04 | 0.03 | Upgrade
|
| Restricted Cash | 0.05 | 0.05 | - | - | 5.74 | - | Upgrade
|
| Other Current Assets | - | - | - | - | 0.27 | - | Upgrade
|
| Total Current Assets | 10.07 | 1.33 | 0.57 | 2.15 | 6.47 | 0.33 | Upgrade
|
| Property, Plant & Equipment | 0 | 0.03 | 0.16 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Goodwill | 1.74 | 1.69 | 1.67 | 1.67 | 1.81 | - | Upgrade
|
| Other Intangible Assets | 3.54 | 3.89 | 4.45 | 5.02 | 6.26 | 0.18 | Upgrade
|
| Total Assets | 15.36 | 6.95 | 6.85 | 8.84 | 14.56 | 0.54 | Upgrade
|
| Accounts Payable | 1.33 | 0.97 | 1.44 | 0.88 | 0.82 | 0.66 | Upgrade
|
| Accrued Expenses | 0.96 | 0.07 | 0.04 | 0.35 | 0.4 | 0.15 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 0.32 | Upgrade
|
| Current Portion of Long-Term Debt | 0.52 | 2.14 | 0.08 | - | 2.52 | - | Upgrade
|
| Current Portion of Leases | - | 0.03 | 0.12 | - | - | 0.02 | Upgrade
|
| Current Income Taxes Payable | 0.03 | 0.03 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | 0.38 | 0.05 | 0.04 | - | - | - | Upgrade
|
| Other Current Liabilities | 0.01 | 0.01 | 0.01 | 0.01 | 6.01 | - | Upgrade
|
| Total Current Liabilities | 3.23 | 3.29 | 1.73 | 1.23 | 9.75 | 1.15 | Upgrade
|
| Long-Term Debt | 18.74 | 5.72 | 7.16 | 5.61 | 4.58 | - | Upgrade
|
| Long-Term Leases | - | - | 0.04 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.18 | 0.35 | 0.92 | 0.1 | Upgrade
|
| Total Liabilities | 21.97 | 9.01 | 9.11 | 7.19 | 15.25 | 1.25 | Upgrade
|
| Common Stock | 22.65 | 21.36 | 15.07 | 14.19 | 6.81 | 3.42 | Upgrade
|
| Additional Paid-In Capital | - | - | - | - | - | 1.21 | Upgrade
|
| Retained Earnings | -34.88 | -29.3 | -20.61 | -15.81 | -8.7 | -5.35 | Upgrade
|
| Comprehensive Income & Other | 5.62 | 5.88 | 3.27 | 3.28 | 1.2 | - | Upgrade
|
| Shareholders' Equity | -6.61 | -2.06 | -2.26 | 1.66 | -0.69 | -0.71 | Upgrade
|
| Total Liabilities & Equity | 15.36 | 6.95 | 6.85 | 8.84 | 14.56 | 0.54 | Upgrade
|
| Total Debt | 19.26 | 7.88 | 7.41 | 5.61 | 7.1 | 0.34 | Upgrade
|
| Net Cash (Debt) | -9.92 | -7.42 | -7.28 | -3.86 | -6.83 | -0.34 | Upgrade
|
| Net Cash Per Share | -0.05 | -0.04 | -0.08 | -0.06 | -0.13 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 217.73 | 216.43 | 168.79 | 86.01 | 64.31 | 64.31 | Upgrade
|
| Total Common Shares Outstanding | 217.73 | 199.13 | 96.56 | 86.01 | 62.44 | 47.32 | Upgrade
|
| Working Capital | 6.84 | -1.96 | -1.16 | 0.91 | -3.28 | -0.82 | Upgrade
|
| Book Value Per Share | -0.03 | -0.01 | -0.02 | 0.02 | -0.01 | -0.01 | Upgrade
|
| Tangible Book Value | -11.9 | -7.65 | -8.38 | -5.02 | -8.76 | -0.89 | Upgrade
|
| Tangible Book Value Per Share | -0.05 | -0.04 | -0.09 | -0.06 | -0.14 | -0.02 | Upgrade
|
| Machinery | - | 0.02 | 0.02 | 0.04 | 0.04 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.